Page last updated: 2024-11-07

paramethasone and Heart Defects, Congenital

paramethasone has been researched along with Heart Defects, Congenital in 1 studies

Paramethasone: A glucocorticoid with the general properties of corticosteroids. It has been used by mouth in the treatment of all conditions in which corticosteroid therapy is indicated except adrenal-deficiency states for which its lack of sodium-retaining properties makes it less suitable than HYDROCORTISONE with supplementary FLUDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p737)

Heart Defects, Congenital: Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
STEENHOUWER, B1
WAUBANT, C1

Other Studies

1 other study available for paramethasone and Heart Defects, Congenital

ArticleYear
[Paramethasone in cardiology].
    Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille, 1963, Volume: 8

    Topics: Adrenal Cortex Hormones; Cardiology; Heart Defects, Congenital; Humans; Paramethasone

1963